Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog and search the HCV drug pipeline click here; for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.

Alan Franciscus
Editor-in-Chief
HCV Advocate
HBV Advocate

Wednesday, October 31, 2012

Liver transplant survival higher among patients with NASH, HBV; lower for HCV, HCC

LAS VEGAS — Patients who underwent liver transplantation to treat nonalcoholic steatohepatitis, HBV or alcoholic liver disease had higher survival rates than those treated for HCV or hepatocellular carcinoma, according to data presented at the 2012 American College of Gastroenterology Annual Scientific Meeting.

Read more..
Posted by at
Labels: , ,

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)